regeneron covid-19 'antibody cocktail' drug enters late-stage trials
Published 4 years ago • 11K plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
3:53
regeneron president on covid antibody cocktail efficacy and supply chain
-
2:17
regeneron's antibody drug offers strong protection against covid-19
-
5:32
regeneron's science chief on starting clinical trials for covid-19 antibody drug
-
1:08
regeneron receives $450 million federal contract for covid-19 antibody drug
-
3:11
regeneron chief scientist explains promising results for covid-19 antibody cocktail
-
6:58
president donald trump using regeneron cocktail was a wholly appropriate call: dr. scott gottlieb
-
4:21
dr. scott gottlieb says he's surprised trump used regeneron cocktail instead of remdesivir treatment
-
3:55
regeneron is much greater than this covid-19 story: analyst
-
4:45
regeneron ceo on teaming up with roche to develop covid-19 antibody cocktail
-
1:22
regeneron reports positive results on initial data for covid-19 antibody drug
-
1:59
cnbc's meg tirrell explains regeneron's antibody cocktail
-
2:01
regeneron's antibody drug reduces risk of death in some covid patients
-
4:17
regeneron reports antibody drug lowers risk of medical visits by 57%
-
3:19
regeneron aims for covid-19 drug trials by early summer
-
2:55
regeneron ceo on distribution of covid-19 antibody cocktail
-
1:32
president donald trump has received regeneron antibody cocktail after covid-19 diagnosis
-
3:16
regeneron antibody drug shown to prevent symptomatic covid-19
-
2:02
regeneron's antibody drug likely to be in short supply because it's grown in live cells
-
1:26
regeneron to ask fda to expand eua for antibody treatment after positive study results
-
3:46
regeneron requests emergency approval for antibody treatment taken by president donald trump
-
2:14
coronavirus: regeneron, sanofi release preliminary results for kevzara drug trial
-
1:59
significance of regeneron antibody cocktail: former fda chief scott gottlieb